Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-22

Clinical Trial Update: Subthalamic Nucleus (STN) Stimulation and Obsessive-Compulsive Disorder (OCD) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating subthalamic nucleus stimulation for obsessive-compulsive disorder completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Subthalamic Nucleus Deep Brain Stimulation (deep brain stimulation)

Snippet

Sponsor: Marie-laure Welter | Conditions: Obsessive Compulsive Disorder | Phase 1, Phase 2 | Status: COMPLETED